Programs by Government Affairs to Support Patient Journey

STUDY OVERVIEW
BENCHMARK CLASS
STUDY SNAPSHOT
KEY FINDINGS
VIEW TOC AND LIST OF EXHIBITS

Patient advocacy is a critical success factor in the health care industry. Government Affairs and Public Policy functions provide various patient support programs and initiatives designed to engage patients.

Best Practices, LLC undertook this research study to capture industry metrics on the level and type of support that Government Affairs and Public Policy functions provide to positively impact the patient journey. The study includes leading insights and metrics around the activities, timing and funding contribution of Government Affairs and Public Policy groups towards patient advocacy and awareness.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Technology; Diagnostic; Medical Device

Companies Profiled:
Boehringer Ingelheim; Dr Reddy's Laboratories; GlaxoSmithKline ; Shire; Abbvie; Teva Pharmaceutical Industries Ltd; Sanofi; BD; UCB Pharma; Astellas; Janssen; AstraZeneca; Abbott; Genentech; Roche

Study Snapshot

Sixteen survey respondents from 15 companies participated in this study. The majority of study participants worked either at the director, senior director or vice president level. Almost all study participants worked in either Government Affairs or Public Policy roles.

Key topics include:

Patient-Focused Support: Activities & Timing

Scope
Number of Product Supported
Activities
Timing by Phase

Patient-Focused Support: Funding

Investment by Function
Investment Trends
Investment Levels

Key Findings

Partnering with patient advocacy groups is most common engagement activity: Partnering with patient advocacy groups occurs at 87% of benchmarked organizations, while 67% are also active in community outreach programs (e.g., screening events), and influencing payer & federal disease policy.

Table of Contents

Executive Summary� � pp. 3-4�

Research Overview� pp. 4
Participating Companies ��pp. 5-6

Key Findings� pp. 7-10
Patient-Focused Support: �Activities & Timing� pp. 11-22
Patient-Focused Support: �Funding�� pp. 23-30
About Best Practices, LLC� � pp. 31

List of Charts & Exhibits

Functional area represented by benchmark partners

Type of products for which Gov't Affairs/Public Policy (GA/PP) groups conduct patient engagement activities
Therapeutic areas represented by the Gov't Affairs/Public Policy groups
Number of products/brands supported by GA/PP groups
The 6 phases of the patient journey
Patient engagement activities and programs conducted by GA/PP groups
GA/PP patient engagement activities timing by patient journey phase
Investment level into engagement activities by patient journey phase
GA/PP patient engagement – Best Practices
Patient engagement activities funding from GA/PP function
% allocation of total GA/PP budget to patient engagement activities
Total GA/PP patient engagement investment
Functions/Groups investing in patient engagement activities

Patient-Focused Support: How Government Affairs & Public Policy Groups Support the Patient Journey

ID: PSM-307

Features:

Pages: 31

Published: 2014

Delivery Format: Shipped

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6F9F6C7BCF94EB26465257D080045E09F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/patient-focused-support-how-govt-affairs&public-policygroups-support-the-patient-journey
18
19
203.227.249.234
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR